Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming

Genesis

Volumn 54, Issue 7, 2016, Pages 398-406

  Vaseghi, Haley Ruth ^a   Yin, Chaoying ^a   Zhou, Yang ^a   Wang, Li ^a   Liu, Jiandong ^a   Qian, Li ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cell reprogramming; fibroblast cell line; inducible gene expression; MGT

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MYOSIN HEAVY CHAIN ALPHA;

ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; INDUCED CARDIOMYOCYTE; MOUSE; MOUSE EMBRYONIC FIBROBLAST; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REPORTER GENE; TRANSFORMED CELL LINE; TRANSGENE;

EID: 84978910922     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.22947     Document Type: Article

References (24)

1. Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, Gearhart JD. 2013. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol 60:97–106.
2. Christoforou N, Chellappan M, Adler AF, Kirkton RD, Wu T, Addis RC, Bursac N, Leong KW. 2013. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PloS One 8:e63577.
3. Das AT, Zhou X, Vink M, Klaver B, Verhoef K, Marzio G, Berkhout B. 2004. Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem 279:18776–18782.
4. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766–1769.
5. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA. 2002. Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation. Mol Cell Biol 22:2111–2123.
6. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. 2009. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 460:1132–1135.
7. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375–386.
8. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ. 2012. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 110:1465–1473.
9. Jozefczuk J, Drews K, Adjaye J. 2012. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J. Vis. Exp. 64:e3854
10. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, Wahl GM, Belmonte JCI. 2009. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140–1144.
11. Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, Blasco MA, Serrano M. 2009. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460:1136–1139.
12. Ma H, Wang L, Yin C, Liu J, Qian L. 2015. In vivo cardiac reprogramming using an optimal single polycistronic construct. Cardiovasc Res 108:217–219.
13. Marión RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA. 2009. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460:1149–1153.
14. Muraoka N, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Isomi M, Nakashima H, Akiyama M, Wada R, Inagawa K, Nishiyama T, Kaneda R, Fukuda T, Takeda S, Tohyama S, Hashimoto H, Kawamura Y, Goshima N, Aeba R, Yamagishi H, Fukuda K, Ieda M. 2014. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 33:1565–1581.
15. Protze S, Khattak S, Poulet C, Lindemann D, Tanaka EM, Ravens U. 2012. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 53:323–332.
16. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu J, Srivastava D. 2012. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593–598.
17. Song K, Nam Y.-J, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN. 2012. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599–604.
18. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460:1145–1148.
19. Wang L, Liu Z, Yin C, Zhou Y, Liu J, Qian L. 2015a. Improved generation of induced cardiomyocytes using a polycistronic construct expressing optimal ratio of Gata4, Mef2c and Tbx5. J. Vis. Exp. 105:e53426.
20. Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y, Bursac N, Liu J, Qian L. 2015b. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res 116:237–244.
21. Zhao Y, Yin X, Qin H, Zhu F, Liu H, Yang W, Zhang Q, Xiang C, Hou P, Song Z, Liu Y, Yong J, Zhang P, Cai J, Liu M, Li H, Li Y, Qu X, Cui K, Zhang W, Xiang T, Wu Y, Zhao Y, Liu C, Yu C, Yuan K, Lou J, Ding M, Deng H. 2008. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3:475–479.
22. Zheng X, Zhai B, Koivunen P, Shin SJ, Lu G, Liu J, Geisen C, Chakraborty AA, Moslehi JJ, Smalley DM, Wei X, Chen X, Chen Z, Beres JM, Zhang J, Tsao JL, Brenner MC, Zhang Y, Fan C, DePinho RA, Paik J, Gygi SP, Kaelin WG, Zhang Q. 2014. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase. Genes Dev 28:1429–1444.
23. Zhou Y, Wang L, Vaseghi HR, Liu Z, Lu R, Alimohamadi S, Yin C, Fu J.-D, Wang GG, Liu J, Qian L. 2016. Bmi1 is a key epigenetic barrier to direct cardiac reprogramming. Cell Stem Cell 18:382–395.
24. Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA. 2002. Tetracycline-controlled transcriptional regulation systems: Advances and application in transgenic animal modeling. Semin Cell Dev Biol 13:121–128.